Brain Dopaminergic Signaling in Opioid Use Disorders
Clinical trial NCT03190954 · COMPLETED
Trial details
- NCT number
- NCT03190954
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-17
- Primary completion
- 2025-10-27
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.